Mohit Kaushal sold $335k of STLN
director at Starling Oncology, Inc.. 95,719 shares at an average of $3.50, traded Apr 14, 2026, filed Apr 16, 2026.
Score components
- +15RoleDirector
- +15Trade size$335k at market
- +10Share of holdings soldSold 36% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001079973-26-000499, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | SOpen-market sale Common Stock10b5-1 | -57,286 | $3.50 | $201k | 211,016 | Apr 16, 2026 |
| Apr 16, 2026 | SOpen-market sale Common Stock10b5-1 | -38,433 | $3.50 | $135k | 172,583 | Apr 16, 2026 |
Related signals
Other insiders at Starling Oncology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Starling Oncology, Inc. | Brad Hively director | $1.9M 298,853 shares | -42% | |
| 26Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $78k 12,000 shares | +0% | |
| 27Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $95k 18,000 shares | +0% | |
| 26Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $88k 15,000 shares | +0% | |
| 16Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $90k 18,000 shares | +0% | |
| 6Weak | Starling Oncology, Inc. | Yale Podnos Chief Medical Officer | $126k 23,451 shares | -8% | |
| 14Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $57k 12,000 shares | +0% | |
| 18Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $157k 38,500 shares | +0% | |
| 17Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $123k 30,000 shares | +0% | |
| 22Weak | STLNbuy Starling Oncology, Inc. | Jorey Chernett owner | $62k 20,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.